Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引：0
|
作者：
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 697
页数：10
相关论文
共 50 条
  • [1] Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older
    Kim, Min Hwan
    Kim, Gun Min
    Kim, Jee Hung
    Kim, Jee Ye
    Park, Hyung Seok
    Park, Seho
    Cho, Young Up
    Park, Byeong Woo
    Kim, Seung Il
    Sohn, Joohyuk
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (03) : 687 - 697
  • [2] Intermediate HER2 expression predicts poor prognosis in ER (+) breast cancer patients aged 55 and older
    Kim, Min Hwan
    Kim, Gun Min
    Kim, Jee Hung
    Kim, Ji Ye
    Park, Hyung Seok
    Park, Seho
    Cho, Young Up
    Park, Byeong Woo
    Kim, Seung Il
    Sohn, Joo-Hyuk
    CANCER RESEARCH, 2020, 80 (04)
  • [3] Should we target "intermediate expression" of HER2 in older estrogen receptor positive patients?
    Tokumaru, Yoshihisa
    Le, Lan
    Asaoka, Mariko
    Futamura, Manabu
    Ishikawa, Takashi
    Yoshida, Kazuhiro
    Takabe, Kazuaki
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (07) : 4056 - 4059
  • [4] Higher CD73 Expression Is Associated with Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Katsuta, Eriko
    Dasgupta, Subhamoy
    Yan, Li
    Takabe, Kazuaki
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S34 - S34
  • [5] Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis
    Iovino, Francesco
    Diana, Anna
    Carlino, Francesca
    Ferraraccio, Franca
    Antoniol, Giuliano
    Fisone, Francesca
    Perrone, Alessandra
    Zito Marino, Federica
    Panarese, Iacopo
    Tathode, Madhura S.
    Caraglia, Michele
    Gatta, Gianluca
    Ruggiero, Roberto
    Parisi, Simona
    De Vita, Ferdinando
    Ciardiello, Fortunato
    Docimo, Ludovico
    Orditura, Michele
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [6] Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
    Pegram, Mark
    Jackisch, Christian
    Johnston, Stephen R. D.
    NPJ BREAST CANCER, 2023, 9 (01)
  • [7] Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
    Mark Pegram
    Christian Jackisch
    Stephen R. D. Johnston
    npj Breast Cancer, 9
  • [8] MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer
    Watanabe, Manabu
    Shibata, Masahiro
    Inaishi, Takahiro
    Ichikawa, Takahiro
    Soeda, Ikumi
    Miyajima, Noriyuki
    Takano, Yuko
    Takeuchi, Dai
    Tsunoda, Nobuyuki
    Kanda, Mitsuro
    Kikumori, Toyone
    Kodera, Yasuhiro
    Nagino, Masato
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [9] HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
    Li, Shuai
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    BREAST, 2020, 54 : 235 - 241
  • [10] The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
    Zhao, Hengqiang
    Gong, Yiping
    FRONTIERS IN ONCOLOGY, 2021, 11
12345